8Omura GA, Brady MF, Homesley HD, et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol , 1991, 9: 1138-1150.
9van Houwelingen JC, ten Bokkel Huinink WW, van der Burg ME, et al. Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol, 1989 ,7: 769-773.
10Neijt JP, ten Bokkel Huinink WW, van der Burg ME, et al. Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer, 1991, 27: 1367-1372.
1Jayde V, White K, Blomfield P. Symptoms and diagnostic delay in ovarian cancer: A summary of the literature[J]. Contemp Nurse,2009,34(1):55-65.
2Seetharamu N, Kim E, Hochster H, etal. Phase Ⅱ Study of Liposomal Cisplatin (SPI-77) in Platinum-sensitive Recurrences of Ovarian Cancer[J]. Anticancer Res, 2010,30(2): 541-545.
3Yoshihara K, Tajima A, Yahata T, et al. Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets[J]. PLoS One, 2010, 5 (3): e9615.
